StockClub

NAVBQ

NAVBQNavidea Biopharmaceuticals, Inc.$ --
Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc.

NAVBQ

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2023FY2023 Q3
Revenue
0M USD
YoY -100.0%
Operating Income
-2M USD
YoY +56.9%
Net Income
-2M USD
YoY +60.5%
EPS
-0.02$
YoY +90.9%

Revenue

$0
FY2021 Q4$531,513
$531,513
Q4
FY2022 Q1$51,007
$51,007
Q1
FY2022 Q2$57,526
$57,526
Q2
FY2022 Q3$65,042
$65,042
Q3
FY2022 Q4$65,652
$65,652
Q4
FY2023 Q1$0
$0
Q1
FY2023 Q2$0
$0
Q2
FY2023 Q3$0
$0
Q3
Actual
$-65,042 (-100.0%)

Net Income

$2.3M
FY2021 Q4$-11.7M
$-11.7M
Q4
FY2022 Q1$-3M
$-3M
Q1
FY2022 Q2$-6M
$-6M
Q2
FY2022 Q3$-11.7M
$-11.7M
Q3
FY2022 Q4$-15.2M
$-15.2M
Q4
FY2023 Q1$-1.5M
$-1.5M
Q1
FY2023 Q2$4.6M
$4.6M
Q2
FY2023 Q3$2.3M
$2.3M
Q3
Actual
+$14M (+119.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017
Actual:$1.8M
FY2017
$1.8M
FY2018
Actual:$322,521
FY2018
$322,521
FY2019
Actual:$26,618
FY2019
$26,618
FY2020
Actual:$915,013
FY2020
$915,013
FY2021
Actual:$531,513
FY2021
$531,513
FY2022
Actual:$65,652
FY2022
$65,652

Analyst Estimates